Aesthetic Philosophy · The Journal
Beyond the 11s: The Expanding Role of Neurotoxins in Facial Balancing and Emotional Aesthetics
Expression-refining treatment that protects warmth, movement, and emotional authenticity.
By Taliah Williamson · The Woodlands, TX
Foreword
Neurotoxin treatment has evolved beyond its early reputation as a wrinkle-erasing solution for the forehead.
Today, precise placement can support facial balance, soften unwanted tension, and help a person’s resting expression feel more aligned with how they feel, without sacrificing movement. Taliah Williamson approaches these possibilities through anatomy, restraint, consent, and respect for the face’s emotional language.
About the Author
Taliah Williamson is a certified cosmetic injector and founder of Tula Tu Aesthetics. Her work combines facial anatomy, precision neurotoxin injection, patient education, and individualized anti-aging strategies designed around natural expression.
01
From line-reducing to expression-refining
Neurotoxins have traditionally softened dynamic lines such as the 11s, crow’s feet, and forehead creases. More nuanced treatment asks a different question: not simply what can be erased, but what can be recalibrated.
Many patients do not want to look younger so much as less angry, sad, or tired. Strategic placement can soften a downturned mouth, relax an overly tense jaw, or gently support a fatigued brow while preserving recognizably human expression.
02
The psychology of expression
The face is a communication tool. Research in emotional perception suggests that persistent frowning or tension, even at rest, can influence how others read a person and how that person experiences their own expression.
Research has explored mood and social engagement following treatment of expressions commonly read as sad or angry. These findings remain an evolving area of study and are not a substitute for mental-health care.
03
Functional zones of the lower face and neck
Beyond the glabella, several muscle groups influence both appearance and function. Each requires conservative dosing and a detailed understanding of movement.
- DAO
- Softens the downward pull at the mouth corners for a calmer resting expression.
- Mentalis
- Reduces chin tension and dimpling that can make the lower face appear strained.
- Platysma
- Supports jawline definition and softens prominent neck bands in a Nefertiti Lift.
- Masseter
- Can refine a broad lower face while supporting people affected by clenching and jaw tension.
These areas can restore balance when they are assessed as part of the whole face, not as isolated items on a treatment menu.
04
Facial balancing and harmonization
Facial balancing aims to ensure no single feature dominates the face’s emotional tone. Neurotoxins can play a subtle role when one brow sits higher, a hyperactive mentalis creates shadowing, or enlarged masseters broaden the lower third.
The work depends on reading asymmetry, muscle interplay, bone structure, and the changes that occur through expression, not applying a standard map to every face.
05
Avoiding over-freeze and expression loss
Overuse can diminish emotional nuance and create the very outcome many first-time patients fear: an inexpressive or unfamiliar face.
- Start subtle
- Use conservative dosing in expression-heavy areas and assess the response.
- Preserve movement
- Allow purposeful contraction where it supports natural expression and brow position.
- Respect identity
- Not every line is a flaw. Character and warmth are part of a face’s beauty.
Ethical treatment aligns with the patient’s goals while protecting function, realistic expectations, and the features that make them recognizable.
06
Expression with intention
Modern neurotoxin care is not limited to erasing lines. It can support symmetry, relieve visible tension, and help a person’s expression feel more consistent with their inner state.
As this approach grows, education and consent must grow with it. The future is not expression suppression; it is thoughtful, individualized treatment that lets a face remain fully itself.
References
Hess U, Thibault P. (2013). “Facial appearance and impression formation.” Philosophical Transactions of the Royal Society B, 368(1629), 20130035.
Wollmer MA, et al. (2016). “Facing depression with botulinum toxin: A randomized controlled trial.” Plastic and Reconstructive Surgery, 138(2), 233–239.
Kane MA. (2010). “Classification and treatment of the aging face with botulinum toxin.” Clinics in Dermatology, 22(1), 71–76.
American Society for Aesthetic Plastic Surgery. (2022). Consumer Trends Report.
A thoughtful treatment plan begins with your features, goals, and questions.